4-bromo-1-ethyl-5-methyl-1H-imidazole, 1g

(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine，(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine （1：1）, 97%, 1g

Methyl 4-bromo-2-fluorobenzoate, 97.0%, 5g

2'-Hydroxypropiophenone, 95.0%, 100g

Tuyau Versilic®, 3,0 mm, 6,0 mm, 50 m,

2-Chlorobenzenebutanoic acid, 97%, 25g

3-(2-Fluoro-phenoxy)propanenitrile, 97.0%, 1g

(2R,3R,4R,5S)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, 98%, 1g

(5E)-5-(3-hydroxybenzylidene)-1,3-thiazolidine-2,4-dione, 95.0%, 1g

3,4-Difluoro-2-ethoxyphenylboronic acid, 98%, 500mg

1-Decyl-3-methylimidazolium Tetrafluoroborate>98.0%(HPLC)(N)5g

4-(1,4-DIMETHYLPIPERIDIN-4-YL)ANILINE, 95.0%, 5g

Fmoc-Pen(Trt)-OH, 98%, 10g